Idelvion IV 250 (albutrepenonacog alpha), manufactured by CSL Behring, is an injectable recombinant factor IX therapy fused with albumin, used for the treatment and prevention of bleeding in patients with hemophilia B. It has a YJ code of 6343448D1020 and a standard of 250 IU 1 bottle (with dissolving liquid).
Idelvion IV 250
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →